Cardiovascular mortality in hypertensive men according to presence of associated risk factors

被引:119
作者
Thomas, F [1 ]
Rudnichi, A [1 ]
Bacri, AM [1 ]
Bean, K [1 ]
Guize, L [1 ]
Benetos, A [1 ]
机构
[1] Ctr IPC, F-75784 Paris 16, France
关键词
hypertension; essential; risk factors; blood pressure; mortality;
D O I
10.1161/01.HYP.37.5.1256
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
To evaluate the risk of cardiovascular disease (CVD) mortality in hypertensive men according to the presence of associated risk factors (ARFs). The population was composed of 29 640 normotensive men without ARFs (reference group) and 60 343 hypertensive men (with and without ARFs) who had a standard health checkup at the Centre d'Investigations Preventives et Cliniques between 1978 and 1988. Mortality data for a mean period of 14 years were analyzed. The following ARFs were considered: total cholesterol greater than or equal to2.5 g/L, personal history of diabetes, smoking (current smokers), body mass index >28 kg/m(2), and heart rate >80 bpm. CVD risk related to the presence of isolated hypertension (assessed in hypertensive subjects without ARFs versus the reference group) increased linearly from 15% at the age of 30 years to 134% at the age of 80 years. In hypertensive subjects, one additional ARF increased CVD risk by 56% (47% to 65%, P<0.01) in younger subjects but only by 4% (-8% to 17%, P=NS) in older subjects. The role of hypercholesterolemia and tobacco smoking in CVD mortality was significantly higher in hypertensive subjects aged <55 years than in hypertensive subjects aged greater than or equal to 55 years (P<0.01), whereas the roles of tachycardia and obesity were not affected by age. In younger hypertensive subjects, evaluation of CVD risk and therapeutic strategies should target ARFs. In older subjects, the presence of high blood pressure levels seems to be the major determinant of CVD risk.
引用
收藏
页码:1256 / 1261
页数:6
相关论文
共 20 条
[1]  
[Anonymous], 1997, ARCH INTERN MED, V157, P2413, DOI DOI 10.1001/ARCHINTE.1997.00440420033005
[2]   Pulse pressure -: A predictor of long-term cardiovascular mortality in a French male population [J].
Benetos, A ;
Safar, M ;
Rudnichi, A ;
Smulyan, H ;
Richard, JL ;
Ducimetière, P ;
Guize, L .
HYPERTENSION, 1997, 30 (06) :1410-1415
[3]   How can hypertensive patients be better treated? The contribution of combination therapy [J].
Benetos, A ;
Guize, L ;
Rudnichi, A ;
Safar, M ;
Asmar, R ;
Bean, K .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2000, 35 :S13-S16
[4]   Increased pulse pressure and risk of heart failure in the elderly [J].
Chae, CU ;
Pfeffer, MA ;
Glynn, RJ ;
Mitchell, GF ;
Taylor, JO ;
Hennekens, CH .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 281 (07) :634-639
[5]  
Chalmers J, 1999, J HYPERTENS, V17, P151
[6]   BLOOD-PRESSURE, STROKE, AND CORONARY HEART-DISEASE .2. SHORT-TERM REDUCTIONS IN BLOOD-PRESSURE - OVERVIEW OF RANDOMIZED DRUG TRIALS IN THEIR EPIDEMIOLOGIC CONTEXT [J].
COLLINS, R ;
PETO, R ;
MACMAHON, S ;
HEBERT, P ;
FIEBACH, NH ;
EBERLEIN, KA ;
GODWIN, J ;
QIZILBASH, N ;
TAYLOR, JO ;
HENNEKENS, CH .
LANCET, 1990, 335 (8693) :827-838
[7]  
Franklin SS, 1997, CIRCULATION, V96, P308
[8]   Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension:: principal results of the hypertension optimal treatment (HOT) randomised trial [J].
Hansson, L ;
Zanchetti, A ;
Carruthers, SG ;
Dahlöf, B ;
Elmfeldt, D ;
Julius, S ;
Ménard, J ;
Rahn, KH ;
Wedel, H ;
Westerling, S .
LANCET, 1998, 351 (9118) :1755-1762
[9]   THE CLINICAL HETEROGENEITY OF HYPERTENSION [J].
KANNEL, WB .
AMERICAN JOURNAL OF HYPERTENSION, 1991, 4 (03) :283-287
[10]  
KANNEL WB, 2000, AM J HYPERTENS 2, V0013